Fundz

Actym Therapeutics Appoints Thomas Smart as Chief Executive Officer

PRIVATEApr 24, 2024

Position

Chief Executive Officer

Company

Actym Therapeutics

Thomas Smart
tsmart@actymthera.com
BerkeleyBiotechnologyHealth CareMedicalTherapeutics

Description

Actym Therapeutics announced the appointment of Thomas Smart as Chief Executive Officer. With 25 years of experience in senior management and executive roles across the biopharmaceutical industry, Mr. Smart’s appointment follows Actym's recent presentations of preclinical data and signifies a strategic move as the company prepares to enter clinical evaluation of its lead candidate, ACTM-838.

Quick answer

Actym Therapeutics Appoints Thomas Smart as Chief Executive Officer (April 24, 2024). Actym Therapeutics is based in Berkeley, California, United States.

Who is the new Chief Executive Officer at Actym Therapeutics?
Actym Therapeutics named Thomas Smart Chief Executive Officer, announced April 24, 2024.
What did Actym Therapeutics announce on April 24, 2024?
Actym Therapeutics announced the appointment of Thomas Smart as Chief Executive Officer. With 25 years of experience in senior management and executive roles across the biopharmaceutical industry, Mr. Smart’s appointment follows Actym's recent presentations of preclinical data and signifies a strategic move as the company prepares to enter clinical evaluation of its lead candidate, ACTM-838.
What does Actym Therapeutics do?
Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies.
Where is Actym Therapeutics based?
Actym Therapeutics is based in Berkeley, California, United States.
Which similar companies made leadership changes around the same time?
Immunome Inc. (May 2, 2024), neurocare (May 7, 2024), ALX Oncology (May 7, 2024) and ELIAS Animal Health, LLC (April 10, 2024) also announced leadership changes within 45 days of Actym Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Actym Therapeutics, and when

A new leader at Actym Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Actym Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Actym Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Actym Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Actym Therapeutics

Location

626 BANCROFT WAY

Berkeley, California, United States

About

Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Actym Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

James
Likely contact at this company
••••••••@••••••••

See James's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Actym Therapeutics's next move

Learn about Strategic plan

Actym Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.